Table 1.
Name | Class | Precursor | Characteristics | Conventional HD Reduction Rate (%) | Effect of PBUTs | Ref |
---|---|---|---|---|---|---|
Indoxyl sulfate | Indoles | Tryptophan | PBUT | 30% | CVD, vascular injury, bone disease, and nephrotoxicity | [46,47,48,49] |
Indole3 Acetic Acid | Indoles | Tryptophan | PBUT | 40% | Cardiovascular dysfunction, endothelial damage, and cognitive impairment | [50,51,52] |
Kynurenine, kynurenic acid, quinolinic acid | Kinurenine pathway | Tryptophan | PBUT | 20% | Cardiovascular dysfunction and cognitive impairment | [53,54] |
Hippuric Acid | Hippurates | Benzoic acid | PBUT | 60–70% | Renal fibrosis and endothelial dysfunction | [55,56] |
P-cresyl sulfate | Phenols | Tyrosine | PBUT | 30% | Cardiovascular damage, renal tubular injury, and insulin resistance | [57,58,59] |
P-cresyl glucuronide | Phenols | Tyrosine | PBUT | 70% | Vascular damage | [60] |
TMAO | Amine oxide | Choline, betaine, carnitine | Water-soluble compound | 80% | CVD and renal inflammation | [61,62,63] |
Abbreviations: HD, hemodialysis; PBUTs, protein-bound uremic toxins; CVD, cardiovascular disease.